-Livemint.com The focus should be more on making the prime minister’s crop insurance scheme a success than demanding farm loans waivers from banks Last week, the Indian National Congress at the Maharashtra assembly submitted a breach of privilege notice against State Bank of India chairman Arundhati Bhattacharya for “insulting farmers and the House” by her remarks on farm loan waiver. The leader of the opposition in the state assembly, Radhakrishna Vikhe Patil,...

-The Hindu Social security cover for all, even informal workers, is an ambitious target for the Centre and stumbling blocks pave its path. The Union government on Thursday proposed an ambitious law to provide social security net to the 47.41 crore-strong workforce of the country. The proposed code on ‘Social Security and Welfare’ intends to make a drastic shift in the social security framework of the country from an employment-based approach to a...

-Down to Earth It is estimated that saving one-fourth of the food currently lost or wasted globally would be enough to feed 870 million hungry people in the world Agriculture, along with its allied sectors, is the largest source of livelihood in India. About 82 per cent of the country’s farmers are small and marginal, having holdings less than one hectare. Over the years, irrigation potential has increased largely due to increased...

-The Indian Express Farmer producer organisations have truly taken off. Now’s the time to create their own lobbying platform. In the summer of 2011, as the managing director of the Small Farmers’ Agribusiness Consortium (SFAC), an autonomous society under the Union Agriculture Ministry, I addressed a group of Uttar Pradesh government officials in Lucknow. My hosts politely sat through my presentation and near-evangelical pitch, as I pushed the idea of promoting farmer...

-The Hindu In 2014, an Indian pharmaceutical company was globally the first to receive approval to market a biosimilar, thereby affordable version, of the breast cancer drug Trastuzumab. Almost immediately, Swiss pharmaceutical company Roche, innovator of the drug, filed a suit against the Indian Food & Drug Administration (FDA) to block its sale. The action firmly put their profits ahead of the lives of women with breast cancer. Roche effectively embroiled India’s...